R&D and New Business Investment Through the Future Investment Committee
First written in FY2019. 10 of 15 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「For its manufacturing-industry projects, the Company worked to develop simulator tools to automate and improve testing and to enhance software architecture, with the aim of improving productivity and quality in software development. Research and development expenses related to the manufacturing-industry projects were ¥6.539 million.」
Through the Future Investment Committee’s research and development framework, the Company developed simulator tools to automate and improve testing and enhanced its software architecture, recording research and development expenses of ¥6.539 million. - FY2025RestatedAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥6.051 million.」
The Company continued its research and development framework through the Future Investment Committee and carried out research and development on its own solutions for the manufacturing industry and FlexSignal. - FY2025-H1RestatedAnnual report
「The amount spent on research and development activities during the interim accounting period was ¥2.095 million. There were no material changes in the status of the Company’s research and development activities during the interim accounting period.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥2.095 million for the interim accounting period. - FY2024AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥31.858 million.」
Under the Future Investment Committee framework, the Company carried out research and development on the PLUSFORCE-related production and warehouse management systems, its own solutions and FlexSignal, resulting in research and development expenses of ¥31.858 million. - FY2024-Q3RestatedAnnual report
「The amount spent on research and development activities during the cumulative third quarter was ¥14.548 million. There were no material changes in the status of the Company’s research and development activities during the cumulative third quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥14.548 million for the cumulative third quarter. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development activities during the cumulative second quarter was ¥9.515 million. There were no material changes in the status of the Company’s research and development activities during the cumulative second quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥9.515 million for the cumulative second quarter. - FY2024-Q1RestatedAnnual report
「The amount spent on research and development activities during the cumulative first quarter was ¥5.038 million. There were no material changes in the status of the Company’s research and development activities during the cumulative first quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥5.038 million for the cumulative first quarter. - FY2023-Q3RestatedAnnual report
「The amount spent on research and development activities during the cumulative third quarter was ¥4.389 million. There were no material changes in the status of the Company’s research and development activities during the cumulative third quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥4.389 million for the cumulative third quarter. - FY2023-Q1RestatedAnnual report
「The amount spent on research and development activities during the cumulative first quarter was ¥499,000. There were no material changes in the status of the Company’s research and development activities during the cumulative first quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥499,000 for the cumulative first quarter. - FY2022-Q3RestatedAnnual report
「The amount spent on research and development activities during the cumulative third quarter was ¥3.368 million. There were no material changes in the status of the Company’s research and development activities during the cumulative third quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥3.368 million for the cumulative third quarter. - FY2022-Q1RestatedAnnual report
「The amount spent on research and development activities during the cumulative first quarter was ¥1.353 million. There were no material changes in the status of the Company’s research and development activities during the cumulative first quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥1.353 million for the cumulative first quarter. - FY2021AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥16.62 million.」
Under the Future Investment Committee framework, the Company carried out several research and development projects, including FlexSignal, joint AUTOSAR research, a cloud-based construction information management system and a sales management system, resulting in research and development expenses of ¥16.62 million. - FY2021-Q3RestatedAnnual report
「The amount spent on research and development activities during the cumulative third quarter was ¥13.242 million. There were no material changes in the status of the Company’s research and development activities during the cumulative third quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥13.242 million for the cumulative third quarter. - FY2020AdvancedAnnual report
「¥20 million of the annual development budget is recorded as the Future Investment budget. Applications for development projects are deliberated and assessed by the Future Investment Committee, attended by the President, division heads and outside experts, to determine whether they are effective for the Company’s medium- to long-term business strategy.」
Under the Future Investment Committee framework, the Company carried out projects including joint AUTOSAR development, FlexSignal version upgrades and cloud system development, and recorded research and development expenses of ¥12.731 million. - FY2019First statedAnnual report
「The Future Investment Committee is a body that deliberates and reviews investment proposals concerning research and development and education aimed at the medium- to long-term growth of the Company’s business, as well as the consideration of new business models and business alliances with other companies.」
A committee chaired by the President deliberates on research and development, education, new business models and alliance projects. The annual Future Investment budget is ¥20 million, and research and development expenses for the fiscal year were ¥21.69 million.